AI assistant
SURMODICS INC — Director's Dealing 2015
Aug 7, 2015
32845_dirs_2015-08-07_12a24803-777c-4034-97ca-3a39108f50a7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2015-08-05
Reporting Person: OLSON CHARLES W (Senior VP & GM, Med Dev)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-05 | Common Stock | S | 5000 | $26.0733 | Disposed | 24390 | Direct |
| 2015-08-05 | Common Stock | S | 5000 | $26.25 | Disposed | 19390 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 800 | Indirect |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2015.
F2: Reflects the weighted average price of 5,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 5, 2015 with sale prices ranging from $25.94 to $26.11 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.